Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

This is an open label study to investigate the efficacy and safety of tradipitant in motion sickness affected male and female participants during events historically known to cause motion sickness.

Inclusion Criteria:

• History of Motion Sickness
• Age 18-75

Exclusion Criteria:

• Nausea-inducing disorder other than motion sickness
• BMI > 40
• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists